Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 26, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $197.27 to $2,046,500.00.

Highlighted Stocks Traded by Insiders:

Colfax (CFX) - FREE Research Report

Kiefaber Clay, who is ESAB Global CEO & EVP - Colfax at Colfax, sold 4,602 shares at $53.20 on Feb. 26, 2015. Following this transaction, the ESAB Global CEO & EVP - Colfax owned 104,221 shares meaning that the stake was reduced by 4.23% with the 4,602-share transaction.

The shares most recently traded at $52.74, down $0.46, or 0.88% since the insider transaction. Historical insider transactions for Colfax go as follows:

  • 4-Week # shares bought: 1,222
  • 4-Week # shares sold: 9,208
  • 12-Week # shares bought: 1,222
  • 12-Week # shares sold: 9,208
  • 24-Week # shares bought: 1,222
  • 24-Week # shares sold: 11,494

The average volume for Colfax has been 1.2 million shares per day over the past 30 days. Colfax has a market cap of $6.6 billion and is part of the industrial goods sector and industrial industry. Shares are up 3.18% year-to-date as of the close of trading on Thursday.

Colfax Corporation, a diversified industrial manufacturing and engineering company, provides gas-and fluid-handling and fabrication technology products and services to commercial and governmental customers worldwide. The company has a P/E ratio of 17.6. Currently, there are 4 analysts who rate Colfax a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFX - FREE

TheStreet Quant Ratings

rates Colfax as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

Colfax Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Genpact (G) - FREE Research Report

Cogny Patrick, who is Senior Vice President at Genpact, sold 19,202 shares at $22.00 on Feb. 26, 2015. Following this transaction, the Senior Vice President owned 0 shares meaning that the stake was reduced by 100% with the 19,202-share transaction.

The shares most recently traded at $22.25, up $0.25, or 1.11% since the insider transaction. Historical insider transactions for Genpact go as follows:

  • 4-Week # shares sold: 6,141
  • 12-Week # shares sold: 6,141
  • 24-Week # shares sold: 6,141

The average volume for Genpact has been 648,400 shares per day over the past 30 days. Genpact has a market cap of $4.8 billion and is part of the services sector and diversified services industry. Shares are up 17.22% year-to-date as of the close of trading on Thursday.

Genpact Limited provides business process management and information technology services worldwide. The company has a P/E ratio of 21.5. Currently, there are 6 analysts who rate Genpact a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on G - FREE

TheStreet Quant Ratings

rates Genpact as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Genpact Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Horizon Bancorp Industries (HBNC) - FREE Research Report

Swinehart Robert E, who is Director at Horizon Bancorp Industries, bought 1,000 shares at $22.62 on Feb. 26, 2015. Following this transaction, the Director owned 27,755 shares meaning that the stake was boosted by 3.74% with the 1,000-share transaction.

The shares most recently traded at $22.84, up $0.22, or 0.96% since the insider transaction. Historical insider transactions for Horizon Bancorp Industries go as follows:

  • 4-Week # shares bought: 4,810
  • 12-Week # shares bought: 4,810
  • 24-Week # shares bought: 4,810

The average volume for Horizon Bancorp Industries has been 19,100 shares per day over the past 30 days. Horizon Bancorp Industries has a market cap of $207.7 million and is part of the financial sector and banking industry. Shares are down 13.39% year-to-date as of the close of trading on Thursday.

Horizon Bancorp operates as the bank holding company for Horizon Bank, N.A. that provides commercial and retail banking services in Northwestern and Central Indiana and Southwest Michigan. The stock currently has a dividend yield of 2.48%. The company has a P/E ratio of 12.3. Currently, there are 2 analysts who rate Horizon Bancorp Industries a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HBNC - FREE

TheStreet Quant Ratings

rates Horizon Bancorp Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Horizon Bancorp Industries Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null